Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study.

ABSTRACT:

Background

Concurrent opioid and stimulant use is on the rise in North America. This increasing trend of use has been observed in the general population, and among people released from prison in British Columbia (BC), who face an elevated risk of overdose post-release. Opioid agonist treatment is an effective treatment for opioid use disorder and reduces risk of overdose mortality. In the context of rising concurrent stimulant use among people with opioid use disorder, this study aims to investigate the impact of stimulant use disorder on opioid agonist treatment dispensation following release from prison in BC.

Methods

Linked health and corrections records were retrieved for releases between January 1^st 2015 and December 29^th 2018 (N = 13,380). Hospita

SUBMITTER: Palis H 

PROVIDER: S-EPMC9694574 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature